Patent ID: 8497298

Claim:
A method for a glucose related disorder selected from the from the group consisting of elevated glucose level, pre-diabetes, impaired oral glucose tolerance, poor glycemic control, Type II Diabetes Mellitus, Syndrome X (also known as metabolic syndrome), gestational diabetes, insulin resistance, hyperglycemia and loss of muscle mass as a results of hyperglycemia comprising administering to a subject in need thereof, a therapeutically effective amount of a compound of formula (I) wherein R 1 and R 2 are each independently selected from the group consisting of hydrogen and lower alkyl; R 4 is selected from the group consisting of hydrogen and lower alkyl; a is an integer from 1 to 2; is selected from the group consisting of wherein b is an integer from 0 to 4; and wherein c is an integer from 0 to 2; each R 5 is independently selected from the group consisting of halogen, lower alkyl and nitro; provided that when then a is 1; or a pharmaceutically acceptable salt thereof.